Beteiligungs GmbH & Co Kg Sanderling VI, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 450,000 shares at $28.19 ($7.1M) on 2013-03-18, disclosed to the SEC on 2013-03-20.
Scheduled sale ($7.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 200,000 | $0 | 0.0% |
| 2 | $28.19 | 29,825 | $841K | 11.9% |
| 3 | $28.19 | 24,688 | $696K | 9.9% |
| 4 | $28.19 | 29,415 | $829K | 11.8% |
| 5 | $29.20 | 28,558 | $834K | 11.8% |
| 6 | $29.20 | 23,969 |
| $700K |
| 9.9% |
| 7 | $29.20 | 28,956 | $846K | 12.0% |
| 8 | $26.95 | 46,339 | $1.2M | 17.7% |
| 9 | $27.66 | 38,250 | $1.1M | 15.0% |
| Total | $15.67 avg | 450,000 | $7.1M | 100% |
| Filing → |